Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

Abstract Background Patients with multiple myeloma (MM) remain at an increased risk of infection due to the disease process, as well as the ensuing treatments. Methods We performed a systematic review to evaluate the monthly risk of grade III/IV infection, pneumonia, and neutropenia in patients with...

Full description

Bibliographic Details
Main Authors: Nicole Balmaceda, Muhammad Aziz, Viveksandeep Thoguluva Chandrasekar, Brian McClune, Suman Kambhampati, Leyla Shune, Al-Ola Abdallah, Faiz Anwer, Aneela Majeed, Muzaffar Qazilbash, Siddhartha Ganguly, Joseph McGuirk, Ghulam Rehman Mohyuddin
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Cancer
Subjects:
Multiple myeloma
Proteasome inhibitors
Anti-CD38
Cytotoxic therapy
Infection
Online Access:https://doi.org/10.1186/s12885-021-08451-x

Internet

https://doi.org/10.1186/s12885-021-08451-x

Similar Items